Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MaZiRenWan (MZRW), also known as Hemp Seed Pill, is a traditional Chinese herbal medicine formulation that has been used for over 2,000 years to treat constipation. Developed for modern clinical use by the School of Chinese Medicine at Hong Kong Baptist University, the core formula consists of six herbal ingredients: Hemp Seed, Rhubarb, Magnolia Bark, Bitter Orange, Bitter Apricot Seed, and White Peony Root. For the treatment of constipation in palliative cancer patients, a modified version combining the MZRW core with HuangQi (Astragalus membranaceus) has been evaluated in Phase 2 clinical trials. The formulation's mechanism of action involves multiple bioactive compounds that enhance gut motility and modulate metabolic pathways, including the regulation of metabolites such as oleamide.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on MaZiRenWan + HuangQi.